Year: 2019

           Le 24 décembre 2019                                                                Information relative au nombre total de droits de vote et d’actions composant le capital social(Article L. 233-8-II du Code de commerce et 223-16 du Règlement général de l’AMF)Place de cotation :       NYSE Euronext-ParisCode ISIN :                 ...

ALBUQUERQUE, N.M., Dec. 24, 2019 (GLOBE NEWSWIRE) — Santa Fe Gold Corporation, (SFEG) OTC, a U.S. based mining company that currently ranks 9th out of the top ten US based mid-tier and junior precious metals companies (as cited by prestigious mining industry trade journal, The Northern Miner), with 148 mining claims covering 42 mine sites is pleased to announce with immediate effect, the appointment to its Board of Directors of Santa Fe Gold, its Geologist / Technical Advisor for Exploration, Development and Mining, Daniel E. Gorski.Mr. Gorski has served as geologist / technical advisor to Santa Fe Gold, since November 2018, and currently also serves as President and CEO of Texas Minerals Resources Corporation, TMRC.Daniel Gorski was appointed President and Chief Executive Officer of Texas Minerals Resources Corporation...

December 24, 2019Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 8,541,356 of its shares. The cancelled shares were acquired as part of Philips’ EUR 1.5 billion share repurchase program that started in the first quarter of 2019. Further details on the repurchase program can be found here. Philips’ current issued share capital amounts to EUR 179,346,744.20 representing 896,733,721 common shares.For further information, please contact:Steve KlinkPhilips Global Press OfficeTel.: +31 6 10888824E-mail: steve.klink@philips.comKsenija GonciarenkoPhilips Investor RelationsTel.: +31 20 5977055E-mail: ksenija.gonciarenko@philips.comAbout Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s...

NEW YORK et CLEVELAND, 24 déc. 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), un leader pleinement intégré en thérapie génique et cellulaire, a annoncé aujourd’hui que l’Agence européenne des médicaments (EMA) a accordé la désignation de Médicament prioritaire (PRIME) au programme ABO-102 de la société, qui étudie sa thérapie génique ponctuelle à base de virus adéno-associé 9 (AAV9) pour le traitement de la maladie de Sanfilippo de type A (MPS IIIA). La désignation PRIME repose sur des données cliniques et non cliniques issues de l’étude Transpher A, un essai clinique mondial de phase 1/2 évaluant une dose unique d’ABO-102...

NEW YORK und CLEVELAND, Dec. 24, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), ein vollständig integrierter Marktführer im Bereich der Gen- und Zelltherapie, hat heute bekanntgegeben, dass die Europäische Arzneimittelagentur (EMA) dem ABO-102-Programm des Unternehmens, im Rahmen dessen die Adeno-assoziierte Virus 9(AAV9)-Gentherapie bei Sanfilippo-Syndrom Typ A (MPS IIIA) untersucht wird, den PRIME-Status für unentbehrliche Medikamente verliehen hat. DerPRIME-Status basiert auf nichtklinischen Daten und klinischen Daten aus der Transpher A-Studie, einer weltweit durchgeführten klinischen Studie der Phase I/II, in der eine Einzeldosis von ABO-102 zur Behandlung von Kindern mit MPS IIIA untersucht wird.„Der PRIME-Status der EMA für das ABO-102-Programm erkennt die dringende Notwendigkeit...

Fort Lauderdale, FL, Dec. 24, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that its CEO, Alexander M. Salgado, will appear this morning on Yahoo Finance’s “On The Move with Adam Shapiro and Julie Hyman,” broadcasting live from 11:00 a.m. to 1:00 p.m. ET.Alexander M. Salgado, CEO and co-founder of Veritas Farms, commented, “The opportunity to discuss Veritas Farms’ recent expansions on a globally streamed business program like Yahoo Finance will put the Veritas Farms™ brand in front of a large audience of potential new customers and investors,...

Ethema signs a non-binding letter of intent to acquire a majority interest in an addiction treatment company with $3.6 million of EBITDAWest Palm Beach, FL, Dec. 24, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Ethema Health Corporation (OTCQB: GRST) (“Ethema” “GRST” or the “Company”), a provider of healthcare services, has announced that it has signed a non-binding Letter of Intent to acquire a majority interest in an addiction treatment company.  The acquisition target will have approximately $20 million in revenue for 2019 and an EBITDA of $3.6 Million.  Under the terms of the LOI the Company would be required to enter into a binding agreement by February 29, 2020 and be closed by April 30, 2020.  The purchase price will be determined during the due diligence process...

TEL AVIV, ISRAEL, Dec. 24, 2019 (GLOBE NEWSWIRE) — Ability Inc. (Nasdaq: ABIL) (the “Company”), a leading provider of innovative tactical communications intelligence solutions, today announced that it received a letter, dated December 23, 2019, from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC informing the Company that the Panel has determined to delist the Company’s ordinary shares from the Nasdaq and will suspend trading in the shares effective at the open of business on December 26, 2019.As previously announced, on November 6, 2019, the Nasdaq informed the Company that it did not meet Nasdaq Listing Rule 5550(b) for continued listing on the Nasdaq Capital Market, which requires the Company to have a minimum of $2,500,000 in stockholders’ equity or market value of listed securities of $35 million...

Company to Fund Water Technology Through Gas RoyaltiesPHOENIX, AZ, Dec. 24, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a sustainability technologies company, announced that the Company has voluntarily terminated the previously announced $25 million Series H convertible preferred equity transaction. This transaction was scheduled to close subject to shareholder approval at the upcoming shareholder meeting in late January 2020. The annual shareholder meeting will also be postponed until later in 2020 as a result of the Series H termination.“We have determined that it is in the best interest of shareholders to focus on spending the royalty income due to Taronis by our previous subsidiary, Taronis Fuels, instead of raising capital at this time,”...

EAST HANOVER, New Jersey, Dec. 24, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SilverSun Technologies, Inc. (NASDAQ: SSNT), a national provider of transformational business technology solutions and services, today announced that its Board of Directors has declared a special cash dividend on the Company’s common stock of $0.50 per share. The record date will be January 7, 2020, and the payment date will be January 14, 2020. “As we continue to execute on our business plan, we believe this special cash dividend is an appropriate way to reward our shareholders for their support,” commented Mark Meller, Chairman and Chief Executive Officer of the Company. “We are fortunate to be able to share the financial success of the Company with our owners, and look forward to more such distributions in the future,...